Avrobio Inc (AVRO)
1.22
+0.03
(+2.52%)
USD |
NASDAQ |
May 01, 16:00
1.21
-0.01
(-0.82%)
After-Hours: 20:00
Avrobio Enterprise Value: -43.27M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | -43.27M |
| April 30, 2024 | -44.62M |
| April 29, 2024 | -44.62M |
| April 26, 2024 | -43.72M |
| April 25, 2024 | -44.84M |
| April 24, 2024 | -44.62M |
| April 23, 2024 | -43.72M |
| April 22, 2024 | -44.17M |
| April 19, 2024 | -44.17M |
| April 18, 2024 | -42.37M |
| April 17, 2024 | -43.27M |
| April 16, 2024 | -41.47M |
| April 15, 2024 | -41.47M |
| April 12, 2024 | -41.03M |
| April 11, 2024 | -41.03M |
| April 10, 2024 | -41.92M |
| April 09, 2024 | -41.47M |
| April 08, 2024 | -41.47M |
| April 05, 2024 | -41.03M |
| April 04, 2024 | -39.23M |
| April 03, 2024 | -39.68M |
| April 02, 2024 | -40.58M |
| April 01, 2024 | -40.58M |
| March 28, 2024 | -40.58M |
| March 27, 2024 | -41.47M |
| Date | Value |
|---|---|
| March 26, 2024 | -41.47M |
| March 25, 2024 | -43.27M |
| March 22, 2024 | -40.58M |
| March 21, 2024 | -41.92M |
| March 20, 2024 | -40.58M |
| March 19, 2024 | -41.47M |
| March 18, 2024 | -40.13M |
| March 15, 2024 | -39.68M |
| March 14, 2024 | -41.05M |
| March 13, 2024 | -40.15M |
| March 12, 2024 | -40.60M |
| March 11, 2024 | -39.70M |
| March 08, 2024 | -39.25M |
| March 07, 2024 | -39.25M |
| March 06, 2024 | -38.18M |
| March 05, 2024 | -39.96M |
| March 04, 2024 | -39.52M |
| March 01, 2024 | -38.62M |
| February 29, 2024 | -39.52M |
| February 28, 2024 | -39.07M |
| February 27, 2024 | -39.96M |
| February 26, 2024 | -39.96M |
| February 23, 2024 | -40.86M |
| February 22, 2024 | -40.41M |
| February 21, 2024 | -39.96M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-118.31M
Minimum
Mar 07 2022
673.96M
Maximum
Feb 11 2020
127.18M
Average
33.04M
Median
Nov 10 2021
Enterprise Value Benchmarks
| Axonics Inc | 3.079B |
| Catalent Inc | 14.90B |
| AIM ImmunoTech Inc | 7.080M |
| Protalix BioTherapeutics Inc | 64.08M |
| Armata Pharmaceuticals Inc | 155.54M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.785M |
| Total Expenses (Quarterly) | 9.627M |
| EPS Diluted (Quarterly) | -0.20 |
| Earnings Yield | 22.13% |